News >

Chemoimmunotherapy Transforms Treatment in Nonsquamous NSCLC

Caroline Seymour
Published: Thursday, Oct 31, 2019

Edward S. Kim, MD, chair of the Department of Solid Tumor Oncology at Levine Cancer Institute,

Edward S. Kim, MD

The combination of immunotherapy and chemotherapy has shown unprecedented survival in patients with newly diagnosed advanced nonsquamous non–small cell lung cancer (NSCLC), said Edward S. Kim, MD.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication